Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

Clicks: 567
ID: 113324
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #7 of 46 articles by views in the pediatric infectious disease journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Efficacy of the PFP-2 vaccine against lower respiratory tract illness during the RSV season was shown in RSV-seropositive children with CF.
Reference Key
pa1996thepurified Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Piedra PA, Grace S, Jewell A, Spinelli S, Bunting D, Hogerman DA, Malinoski F, Hiatt PW
Are you one of these authors? Claim your profile
Journal the pediatric infectious disease journal
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8684872
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Child Infant preschool Clinical Trial Randomized Controlled Trial Double-Blind Method placebos severity of illness index respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* respiratory syncytial viruses / isolation & purification controlled clinical trial cystic fibrosis / complications vaccines viral vaccines / therapeutic use hn protein* viral envelope proteins respiratory syncytial viruses / immunology child nutritional physiological phenomena respiratory syncytial virus infections / complications pmid:8684872 doi:10.1097/00006454-199601000-00006 p a piedra s grace p w hiatt cystic fibrosis / virology* environment respiratory syncytial viruses / chemistry vaccination* synthetic / adverse effects synthetic / immunology synthetic / therapeutic use viral proteins / immunology* viral vaccines / adverse effects viral vaccines / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.